Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Cromoglycate
Drug ID BADD_D00537
Description A chromone complex that acts by inhibiting the release of chemical mediators from sensitized mast cells. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack.
Indications and Usage For the management of patients with bronchial asthma. Also used in the treatment of vernal keratoconjunctivitis, vernal conjunctivitis, and vernal keratitis.
Marketing Status Prescription; OTC; Discontinued
ATC Code A07EB01; D11AH03; R01AC01; R03BC01; S01GX01
DrugBank ID DB01003
KEGG ID D07753
MeSH ID D004205
PubChem ID 2882
TTD Drug ID D0G7IY
NDC Product Code Not Available
Synonyms Cromolyn Sodium | Sodium Cromoglycate | Cromoglycate, Sodium | Disodium Cromoglycate | Cromoglycate, Disodium | Aarane | Bicromat Spray | Cromoglycate | Opticrom | FPL-670 | FPL 670 | FPL670 | Intal | Lomudal | Nalcrom | Nasalcrom | Vicrom | Cromolyn | Cromoglicic Acid | Acid, Cromoglicic | Cromoglycic Acid | Acid, Cromoglycic
Chemical Information
Molecular Formula C23H16O11
CAS Registry Number 16110-51-3
SMILES C1=CC2=C(C(=C1)OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)O)O)C(=O)C=C(O2)C(=O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Type I hypersensitivity10.01.03.006--Not Available
Urticaria23.04.02.001; 10.01.06.001--
Vascular purpura24.07.06.011; 23.06.01.008; 01.01.04.007--Not Available
Vasculitis10.02.02.006; 24.05.02.001--
Ventricular extrasystoles02.03.04.007--Not Available
Vertigo17.02.12.002; 04.04.01.003--
Wheezing22.03.01.009--
Conjunctival hyperaemia06.04.01.004--Not Available
Eye pruritus06.04.05.006--Not Available
Nasal discomfort22.02.05.020--Not Available
Foetor hepaticus09.01.05.006; 07.01.06.026--Not Available
Musculoskeletal stiffness15.03.01.005--Not Available
Musculoskeletal discomfort15.03.04.001--Not Available
Affect lability19.04.01.001--Not Available
Ill-defined disorder08.01.03.049--Not Available
Psychotic disorder19.03.01.002--
Nasal pruritus22.04.03.018--Not Available
The 4th Page    First    Pre   4    Total 4 Pages